Celyad SA Stock Forecast NASDAQ:CYAD

Price Target and Analyst Ratings

Most Recent Rating

On August 20, 2021 "Jonestrading" gave "" rating for CYAD. The price target was changed from $4.02 to 2.0%.

Last 30 Days

Historical Ratings

Date	Rating	Action	Authority	Current Price	Target Price
2021-08-20		Reiterated by	Jonestrading	$3.88	$4.02→2.0%
2021-08-06	$17.00 - $15.00	Target Lowered by	HC Wainwright	$4.30	$4.29+0.7%
2021-05-17	Buy	Target Lowered by	HC Wainwright	$5.57	$18.00 → $17.00
2021-05-10	Buy	Target Lowered by	HC Wainwright	$5.71	$18.00 → $17.00
2021-03-31	Buy - Hold	Reiterated by	Jonestrading	$7.03
2021-03-25	Buy - Hold	Downgraded by	Jonestrading	$7.30
2020-12-08	Buy	Target Lowered by	HC Wainwright	$8.08	$22.00 → $18.00
2020-09-29	Buy	Reiterated by	William Blair	$9.90
2020-06-01	Buy	Reiterated by	William Blair	$12.47
2020-05-07	Buy	Reiterated by	HC Wainwright	$8.94

CYAD Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -14.83% during the next 3 months and, with a 90% probability hold a price between $3.08 and $4.02 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.

Data

Date	Bottom	Mid	Top
2021-09-22	$3.61	$4.16	$4.70
2021-09-23	$3.59	$4.14	$4.69
2021-09-24	$3.58	$4.13	$4.68
2021-09-27	$3.57	$4.12	$4.67
2021-09-28	$3.55	$4.10	$4.65
2021-09-29	$3.54	$4.09	$4.64
2021-09-30	$3.53	$4.08	$4.63
2021-10-01	$3.51	$4.06	$4.61
2021-10-04	$3.50	$4.05	$4.60
2021-10-05	$3.49	$4.04	$4.59
2021-10-06	$3.48	$4.02	$4.57
2021-10-07	$3.46	$4.01	$4.56
2021-10-08	$3.45	$4.00	$4.55
2021-10-11	$3.44	$3.99	$4.53
2021-10-12	$3.42	$3.97	$4.52
2021-10-13	$3.41	$3.96	$4.51
2021-10-14	$3.40	$3.95	$4.50
2021-10-15	$3.38	$3.93	$4.48
2021-10-18	$3.37	$3.92	$4.47
2021-10-19	$3.36	$3.91	$4.46
2021-10-20	$3.35	$3.89	$4.44
2021-10-21	$3.33	$3.88	$4.43
2021-10-22	$3.32	$3.87	$4.42
2021-10-25	$3.31	$3.86	$4.40
2021-10-26	$3.29	$3.84	$4.39
2021-10-27	$3.28	$3.83	$4.38
2021-10-28	$3.27	$3.82	$4.37
2021-10-29	$3.25	$3.80	$4.35
2021-11-01	$3.24	$3.79	$4.34
2021-11-02	$3.23	$3.78	$4.33

About Celyad SA

Celyad SA, a clinical-stage biopharmaceutical company, focuses on engineered cell therapy treatments. It develops therapeutic therapies for the treatment of unmet medical needs in cardiology and oncology. The company offers C-Cure, an autologous cell therapy for the treatment of heart failure. It also provides NKR-2, an autologous chimeric antigen receptor (CAR), a lab engineered receptor for the treatment of cancer. In addition, the companys p... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!